Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that results from an analysis of 160 real-world patients with ...

Northwestern Medicine scientists have discovered how a specific transcription factor promotes genetic reprogramming and ...

Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that results from a sex-specific analysis of 160 real-world ...

Understanding molecular diversity is fundamental to biomedical research and diagnostics, but existing analytical tools ...

Get key insights from Myriad Genetics’ Q3 2025 earnings call, growth strategies, financial outlook, and new product launches.

With a new type of analysis powered by artificial intelligence, doctors may be able to predict whether or not you’ll develop breast cancer in the future.

The Hong Kong University of Science and Technology (HKUST) today launched SmartPath, a comprehensive artificial intelligence (AI) system designed to transform the entire pathology workflow for cancer ...

The former president's office announced his prostate cancer diagnosis in May. Former President Joe Biden is now receiving radiation therapy for his prostate cancer, a spokesperson for the former ...

Patients were randomized to receive I-DXd 8 or 12 mg/kg intravenously every 3 weeks (Q3W) in part 1 (dose optimization) and received I-DXd 12 mg/kg in part 2 (extension). The primary endpoint was ...

Kerry Breen is a news editor at CBSNews.com. A graduate of New York University's Arthur L. Carter School of Journalism, she previously worked at NBC News' TODAY Digital. She covers current events, ...